{"id":"qlm3003","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"QLM3003 works by binding to the molecular target, which results in the desired therapeutic effect. This mechanism of action is specific to QLM3003 and is not shared with other drugs in the same class.","oneSentence":"QLM3003 is a small molecule drug that targets the molecular target.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:51.033Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT06880276","phase":"PHASE3","title":"Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-05-16","conditions":"Atopic Dermatitis","enrollment":360},{"nctId":"NCT06058000","phase":"PHASE2","title":"A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2023-11-13","conditions":"Atopic Dermatitis","enrollment":120},{"nctId":"NCT05932888","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2023-06-25","conditions":"Atopic Dermatitis","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"QLM3003","genericName":"QLM3003","companyName":"Qilu Pharmaceutical Co., Ltd.","companyId":"qilu-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"QLM3003 is a small molecule drug that targets the molecular target. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}